One notable difference is that tirzepatide is a dual-agonist (GLP-1 and GIP) while retatrutide is a triple-agonist (GLP-1, GIP, and glucagon)
Rotunda W, Rains C, Jacobs SR, et al
Together, they can pack a powerful punch
Experimental Self-Treatment: Current human use of BPC-157 largely falls under the category of experimental self-treatment
But to make a difference, we need to drill into specific central nervous system pathways to understand which patient populations should be closely monitored for tolerability and efficacy versus which ones are more stable. Genetic makeup can be viewed as a series of regulators, meaning theres no single gene that causes obesity
Limitations and Mixed Results Many studies have small sample sizes or short durations, making it hard to draw firm conclusions